ImportRefusal LogoImportRefusal

Huisong Pharmaceuticals

⚠️ Moderate Risk

FEI: 3009881519 • Hangzhou, Zhejiang • CHINA

FEI

FEI Number

3009881519

📍

Location

Hangzhou, Zhejiang

🇨🇳

Country

CHINA
🏢

Address

168 Jiuheng Road, Jiubao, Hangzhou, Zhejiang, China

Moderate Risk

FDA Import Risk Assessment

44.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
10
Unique Violations
12/21/2021
Latest Refusal
8/13/2008
Earliest Refusal

Score Breakdown

Violation Severity
68.1×40%
Refusal Volume
42.5×30%
Recency
18.8×20%
Frequency
9.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

23003×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

2493×

FILTHY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.

38633×

PLANT PART

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(C) of the FD&C Act in that the supplement contains an herb or other botanical described in section 201(ff)(1)(C), and the label or labeling of the supplement fails to identify any part of the plant from which the ingredient is derived.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

31402×

SBGINSENG

The article is subject to refusal of admission in that it appears to be Misbranded because it or its ingredients purport to be or are represented as Ginseng, but are not an herb or herbal ingredient derived from a plant classified within the genus Panax.

2382×

UNSAFE ADD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.

2412×

PESTICIDE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a pesticide chemical residue, which causes the article to be adulterated within the meaning of section 402(a)(2)(B) of the FD&C Act. Bears or contains:

29201×

PESTICIDES

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be adulterated because it contains a pesticide chemical, which is in violation of section 402(a)(2)(B). Contains:

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

3211×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

Refusal History

DateProductViolationsDivision
12/21/2021
25QGH04MUSHROOM, SHIITAKE, PIECES AND STEMS, SLICED
249FILTHY
Division of West Coast Imports (DWCI)
12/21/2021
25QGH04MUSHROOM, SHIITAKE, PIECES AND STEMS, SLICED
249FILTHY
Division of West Coast Imports (DWCI)
9/28/2021
54FBY12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
241PESTICIDE
Division of Southeast Imports (DSEI)
1/31/2020
54FAR12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
241PESTICIDE
Division of Northeast Imports (DNEI)
11/6/2015
25SGH04MUSHROOM, SHIITAKE, FUNGI PRODUCTS, N.E.C.
249FILTHY
San Francisco District Office (SAN-DO)
4/14/2015
54FCR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
3863PLANT PART
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/14/2015
54FCR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
3863PLANT PART
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/14/2015
54FCR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
3863PLANT PART
75UNAPPROVED
Los Angeles District Office (LOS-DO)
2/8/2013
54YYY04GINSENG UNCONVENTIONAL DIETARY SPECIALITY FOR HUMANS OR ANIMALS
3140SBGINSENG
Southwest Import District Office (SWI-DO)
9/14/2012
45TG99ALL OTHER PRODUCTS, NON-NUTRITIVE SWEETENERS
238UNSAFE ADD
New Orleans District Office (NOL-DO)
12/3/2009
54FBR12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
3140SBGINSENG
Los Angeles District Office (LOS-DO)
10/29/2009
54EBT99HERBALS & BOTANICAL TEAS, N.E.C.
238UNSAFE ADD
320LACKS FIRM
321LACKS N/C
San Francisco District Office (SAN-DO)
8/13/2008
54FBR12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
2920PESTICIDES
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Huisong Pharmaceuticals's FDA import refusal history?

Huisong Pharmaceuticals (FEI: 3009881519) has 13 FDA import refusal record(s) in our database, spanning from 8/13/2008 to 12/21/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Huisong Pharmaceuticals's FEI number is 3009881519.

What types of violations has Huisong Pharmaceuticals received?

Huisong Pharmaceuticals has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Huisong Pharmaceuticals come from?

All FDA import refusal data for Huisong Pharmaceuticals is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.